drugset / Trial / NCT03111433

Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus

NCT03111433

Phase 2 Completed 49 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine wether coenzyme Q10 is effective in reducing markers of endothelial dysfunction in pediatric patients with type 1 diabetes mellitus and aslo to investigate its effect on glycemic control and lipid profile of those patients and its effect on patient's quality of life.

Timeline

Start
2017-03-19
Primary completion
2018-01-20
Completion
2018-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified 100 mg
Background Insulin Protein / enzyme biologic